Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
4.010
+0.010 (0.25%)
At close: Sep 21, 2026, 4:00 PM EDT
3.970
-0.040 (-1.00%)
After-hours: Sep 21, 2026, 7:30 PM EDT
IMDX Market Cap
IMDX has a market cap or net worth of $131.22 million as of September 21, 2026. Its market cap has increased by 34.45% in one year.
Market Cap
131.22M
Enterprise Value
116.09M
1-Year Change
34.45%
Ranking
Category
Stock Price
$4.01
ChartMarket Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $131.22M, a decrease of -42.62%. That is a compound annual growth rate of -5.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 131.22M | -38.97% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.25B |
| Castle Biosciences | 1.08B |
| Fulgent Genetics | 596.81M |
| Myriad Genetics | 372.08M |
| Biodesix | 308.09M |
| Exagen | 203.74M |
| Burning Rock Biotech | 150.13M |
| Quantum Cyber | 116.01M |